Cytokinetics(DE:KK3A)
€51.56-0.90 (-1.72%)
DE:KK3A
Cytokinetics earnings date
€51.56
At close:-0.90 (-1.72%)
Cytokinetics (KK3A) Q2 2026 Earnings Report
4 Followers
DE:KK3A Q2 2026 EPS Results
- Actual EPS
- -EUR 1.34
- Consensus EPS
- -EUR 1.46
- Beat/Miss
- Beat by +EUR 0.11
- One Year Ago EPS
- -EUR 1.00
DE:KK3A Q2 2026 Revenue Results
- Actual Revenue
- EUR 25.63M
- Expected Revenue
- EUR 15.75M
- Beat/Miss
- Beat by +EUR 9.88M
- YoY Revenue Growth
- -57.13%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/06/2026
- Time
- After Close
- Conference Call
- Thursday, August 6, 2026
DE:KK3A Upcoming Earnings
Cytokinetics's next earnings date is estimated for March 2, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
DE:KK3A Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:KK3A Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 02, 2027 | 2026 (Q4) | -1.26- | -1.34 | ― | ― |
| Nov 04, 2026 | 2026 (Q3) | -1.28-1.23 | -2.28 | 46.27% (+1.06) | |
| Aug 06, 2026 | 2026 (Q2) | -1.46-1.34 | -1 | -33.93% (-0.34) | |
| May 05, 2026 | 2026 (Q1) | -1.48-1.50 | -1.22 | -22.79% (-0.28) | |
| Feb 24, 2026 | 2025 (Q4) | -1.40-1.34 | -1.13 | -19.05% (-0.21) | |
| Nov 05, 2025 | 2025 (Q3) | -1.41-2.28 | -1.22 | -87.50% (-1.07) | |
| Aug 07, 2025 | 2025 (Q2) | -1.28-1.00 | -1.17 | 14.50% (+0.17) | |
| May 06, 2025 | 2025 (Q1) | -1.23-1.22 | -1.19 | -2.26% (-0.03) | |
| Feb 27, 2025 | 2024 (Q4) | -1.07-1.13 | -1.24 | 8.70% (+0.11) | |
| Nov 06, 2024 | 2024 (Q3) | -1.11-1.22 | -1.21 | -0.74% (-0.01) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
